Depression involves serotonin, dopamine, and norepinephrine dysregulation, reduced BDNF (leading to hippocampal atrophy), elevated inflammatory cytokines, and HPA axis hyperactivity. Peptide research approaches mood disorders by supporting neuroplasticity, normalizing neurotransmitter systems, reducing neuroinflammation, and restoring the circadian biology disrupted in depressive states.
1. Selank — Serotonin / GABA Stabilization
Selank stabilizes serotonin metabolism, enhances GABAergic tone, and reduces the excessive norepinephrine signaling that drives anxiety-depression comorbidity. It has demonstrated antidepressant effects in multiple clinical and preclinical studies, particularly for mixed anxiety-depression presentations, with a clean side effect profile.
Dosing Protocol: 250–500 mcg intranasal daily (split AM and early afternoon). SubQ: 300–600 mcg daily. Cycles of 10 days on, 5 days off.
2. Semax — BDNF / Neuroplasticity
Low BDNF is consistently found in depression and is believed to drive the hippocampal volume loss observed in chronic cases. Semax dramatically upregulates BDNF, NGF, and VEGF — the neurotrophic factors needed for neuroplasticity and mood regulation. It also enhances dopaminergic tone, addressing the anhedonia and motivation deficits characteristic of depression.
Dosing Protocol: 300–600 mcg intranasal daily. SubQ: 300–500 mcg daily. Cycle 10 days on / 5 days off.
3. BPC-157 — Gut-Brain / Dopamine-Serotonin Axis
The gut-brain axis is increasingly recognized as central to mood regulation — 90% of serotonin is synthesized in the gut, and gut inflammation drives systemic neuroinflammation. BPC-157 repairs gut barrier integrity, normalizes gut serotonin production, and modulates brain dopamine and serotonin receptor sensitivity directly.
Dosing Protocol: 500 mcg oral BPC-157 (arginate form) daily to address gut-brain axis. Stack with 250 mcg SubQ for combined systemic effects. Cycle: 8–12 weeks.
4. Epithalon — Circadian / Melatonin Restoration
Disrupted circadian biology — particularly melatonin hyposecretion — is both a cause and consequence of depression. Epithalon restores pineal melatonin secretion, normalizes the sleep-wake cycle, and has demonstrated antidepressant effects in aging animal models by restoring the neuroendocrine rhythms disrupted in depressive states.
Dosing Protocol: 5–10 mg SubQ daily for 10-day courses. Rest 30–60 days. Best used as an adjunct to address the circadian component of depression.
Selank and Semax address the neurotransmitter and BDNF deficits driving depression from complementary angles. BPC-157 repairs the gut-brain serotonin production pathway often overlooked in conventional treatment. Epithalon restores the circadian melatonin biology whose disruption perpetuates the sleep dysfunction and HPA dysregulation central to depressive illness.
- Semenova TP et al. (2008). Selank and serotonin regulation. Neuroscience Behav Physiol.
- Eremin KO et al. (2012). Semax BDNF and mood. Biochemistry (Moscow).
- Seiwerth S et al. (2018). BPC-157 and CNS neurotransmitters. Peptides.
- Khavinson VKh et al. (2003). Epithalon and pineal-mood axis. Neuroendocrinology Letters.
Research Use Only. All information on this page is for educational purposes only and is not medical advice. PepSherpa does not sell peptides. Consult a licensed healthcare provider before making any health decisions. Many of the studies cited are preclinical (animal/in-vitro).